Drug-drug interaction analysis using heterogeneous biological information network

Kyubum Lee, Sunwon Lee, Minji Jeon, Jaehoon Choi, Jaewoo Kang

Research output: Chapter in Book/Report/Conference proceedingConference contribution

4 Citations (Scopus)

Abstract

As the number of drugs increases, more prescription choices are available for physicians, and consequently the number of drugs administered together has increased. Researchers are working on finding multi-drug prescriptions that are effective and safe. An efficient method for finding DDIs plays a crucial role in this research. In order to address the problem, we construct a heterogeneous biological information network by combining multiple different databases and interaction information. Our network includes the information about genes, proteins, pathways, drugs, side effects, targets and their interactions. We propose a metric to measure the relation strength between two nodes in the network, which is based on the weighted sum of the numbers of paths containing different interaction types. We use the metric to score DDI candidates. We found that the drugs sharing a disease are more likely to have a DDI than the drugs sharing a biomolecular target, and the metric using the weighted sum of the path numbers is effective to rank the potential DDIs. We validated the result with the PharmGKB DDI dataset and the Drugs.com drug interaction checker.

Original languageEnglish
Title of host publicationProceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012
Pages623-627
Number of pages5
DOIs
Publication statusPublished - 2012 Dec 1
Event2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM2012 - Philadelphia, PA, United States
Duration: 2012 Oct 42012 Oct 7

Other

Other2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM2012
CountryUnited States
CityPhiladelphia, PA
Period12/10/412/10/7

Fingerprint

Drug interactions
Information Services
Drug Interactions
Genes
Proteins
Pharmaceutical Preparations
Drug Prescriptions
Drug-Related Side Effects and Adverse Reactions
Prescriptions
Research Personnel
Databases
Physicians
Research

Keywords

  • biological network
  • DDI
  • drug interaction
  • systems pharmacology

ASJC Scopus subject areas

  • Biomedical Engineering
  • Health Informatics

Cite this

Lee, K., Lee, S., Jeon, M., Choi, J., & Kang, J. (2012). Drug-drug interaction analysis using heterogeneous biological information network. In Proceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012 (pp. 623-627). [6392634] https://doi.org/10.1109/BIBM.2012.6392634

Drug-drug interaction analysis using heterogeneous biological information network. / Lee, Kyubum; Lee, Sunwon; Jeon, Minji; Choi, Jaehoon; Kang, Jaewoo.

Proceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012. 2012. p. 623-627 6392634.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Lee, K, Lee, S, Jeon, M, Choi, J & Kang, J 2012, Drug-drug interaction analysis using heterogeneous biological information network. in Proceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012., 6392634, pp. 623-627, 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM2012, Philadelphia, PA, United States, 12/10/4. https://doi.org/10.1109/BIBM.2012.6392634
Lee K, Lee S, Jeon M, Choi J, Kang J. Drug-drug interaction analysis using heterogeneous biological information network. In Proceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012. 2012. p. 623-627. 6392634 https://doi.org/10.1109/BIBM.2012.6392634
Lee, Kyubum ; Lee, Sunwon ; Jeon, Minji ; Choi, Jaehoon ; Kang, Jaewoo. / Drug-drug interaction analysis using heterogeneous biological information network. Proceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012. 2012. pp. 623-627
@inproceedings{5ec9bde3da984a33b9201f7266c94098,
title = "Drug-drug interaction analysis using heterogeneous biological information network",
abstract = "As the number of drugs increases, more prescription choices are available for physicians, and consequently the number of drugs administered together has increased. Researchers are working on finding multi-drug prescriptions that are effective and safe. An efficient method for finding DDIs plays a crucial role in this research. In order to address the problem, we construct a heterogeneous biological information network by combining multiple different databases and interaction information. Our network includes the information about genes, proteins, pathways, drugs, side effects, targets and their interactions. We propose a metric to measure the relation strength between two nodes in the network, which is based on the weighted sum of the numbers of paths containing different interaction types. We use the metric to score DDI candidates. We found that the drugs sharing a disease are more likely to have a DDI than the drugs sharing a biomolecular target, and the metric using the weighted sum of the path numbers is effective to rank the potential DDIs. We validated the result with the PharmGKB DDI dataset and the Drugs.com drug interaction checker.",
keywords = "biological network, DDI, drug interaction, systems pharmacology",
author = "Kyubum Lee and Sunwon Lee and Minji Jeon and Jaehoon Choi and Jaewoo Kang",
year = "2012",
month = "12",
day = "1",
doi = "10.1109/BIBM.2012.6392634",
language = "English",
isbn = "9781467325585",
pages = "623--627",
booktitle = "Proceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012",

}

TY - GEN

T1 - Drug-drug interaction analysis using heterogeneous biological information network

AU - Lee, Kyubum

AU - Lee, Sunwon

AU - Jeon, Minji

AU - Choi, Jaehoon

AU - Kang, Jaewoo

PY - 2012/12/1

Y1 - 2012/12/1

N2 - As the number of drugs increases, more prescription choices are available for physicians, and consequently the number of drugs administered together has increased. Researchers are working on finding multi-drug prescriptions that are effective and safe. An efficient method for finding DDIs plays a crucial role in this research. In order to address the problem, we construct a heterogeneous biological information network by combining multiple different databases and interaction information. Our network includes the information about genes, proteins, pathways, drugs, side effects, targets and their interactions. We propose a metric to measure the relation strength between two nodes in the network, which is based on the weighted sum of the numbers of paths containing different interaction types. We use the metric to score DDI candidates. We found that the drugs sharing a disease are more likely to have a DDI than the drugs sharing a biomolecular target, and the metric using the weighted sum of the path numbers is effective to rank the potential DDIs. We validated the result with the PharmGKB DDI dataset and the Drugs.com drug interaction checker.

AB - As the number of drugs increases, more prescription choices are available for physicians, and consequently the number of drugs administered together has increased. Researchers are working on finding multi-drug prescriptions that are effective and safe. An efficient method for finding DDIs plays a crucial role in this research. In order to address the problem, we construct a heterogeneous biological information network by combining multiple different databases and interaction information. Our network includes the information about genes, proteins, pathways, drugs, side effects, targets and their interactions. We propose a metric to measure the relation strength between two nodes in the network, which is based on the weighted sum of the numbers of paths containing different interaction types. We use the metric to score DDI candidates. We found that the drugs sharing a disease are more likely to have a DDI than the drugs sharing a biomolecular target, and the metric using the weighted sum of the path numbers is effective to rank the potential DDIs. We validated the result with the PharmGKB DDI dataset and the Drugs.com drug interaction checker.

KW - biological network

KW - DDI

KW - drug interaction

KW - systems pharmacology

UR - http://www.scopus.com/inward/record.url?scp=84872561295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872561295&partnerID=8YFLogxK

U2 - 10.1109/BIBM.2012.6392634

DO - 10.1109/BIBM.2012.6392634

M3 - Conference contribution

AN - SCOPUS:84872561295

SN - 9781467325585

SP - 623

EP - 627

BT - Proceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012

ER -